AGARWALEYE — Dr. Agarwals Health Care Balance Sheet
0.000.00%
- IN₹172.38bn
- IN₹176.87bn
- IN₹17.11bn
Annual balance sheet for Dr. Agarwals Health Care, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 705 | 1,207 | 1,862 | 5,998 | 5,717 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 510 | 659 | 796 | 994 | 1,298 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,545 | 2,275 | 3,102 | 7,586 | 7,941 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,522 | 5,431 | 9,010 | 11,347 | 14,843 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 7,870 | 10,261 | 18,252 | 27,528 | 36,716 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,504 | 2,060 | 3,013 | 3,998 | 4,778 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,028 | 8,138 | 11,956 | 14,134 | 18,050 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1,842 | 2,124 | 6,296 | 13,394 | 18,666 |
| Total Liabilities & Shareholders' Equity | 7,870 | 10,261 | 18,252 | 27,528 | 36,716 |
| Total Common Shares Outstanding |